Aybintio (abaloparatide)
Aybintio is a prescription medicine used to treat osteoporosis in postmenopausal women at high risk…
Hypoparathyroidism results in a disruption of calcium and phosphorus homeostasis, leading to a range of clinical manifestations, including neuromuscular symptoms, cardiac abnormalities, and bone abnormalities. Management typically involves supplementation with calcium and active vitamin D analogs to maintain adequate calcium levels and minimize symptoms associated with hypocalcemia… Read More »